Zentalis Pharmaceuticals (ZNTL) Research & Development (2019 - 2026)
Zentalis Pharmaceuticals' quarterly Research & Development came in at $28.7 million in Q1 2026, up 5.39% year-on-year from $27.2 million in Q1 2025, and down 2.62% quarter-over-quarter from $29.5 million in Q4 2025.
Zentalis Pharmaceuticals has reported Research & Development for 8 years, with the latest figure at $28.7 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 5.39% year-over-year to $28.7 million; the trailing twelve-month figure through Mar 2026 stood at $108.8 million (down 25.21% YoY), and the FY2025 full-year result was $107.3 million, down 36.05% from the prior year.
- Research & Development for Q1 2026 stood at $28.7 million, down from $29.5 million in the prior quarter.
- The five-year high for Research & Development was $51.6 million in Q4 2023, with the low at $23.0 million in Q3 2025.
- Average Research & Development over 5 years is $39.2 million, with a median of $42.2 million recorded in 2022.
- Year-over-year, Research & Development grew 26.94% in 2023 and sank 45.05% in 2025.
- Tracing ZNTL's Research & Development over 5 years: stood at $40.6 million in 2022, then gained by 26.94% to $51.6 million in 2023, then sank by 36.05% to $33.0 million in 2024, then declined by 10.57% to $29.5 million in 2025, then slipped by 2.62% to $28.7 million in 2026.
- The last three Research & Development figures came in at $28.7 million (Q1 2026), $29.5 million (Q4 2025), and $23.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -2.30 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.54 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Zentalis Pharmaceuticals | 280.35 Mn | 280.35 Mn | - | 28.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.72 Mn |
| Dec 31, 2025 | 29.49 Mn |
| Sep 30, 2025 | 22.95 Mn |
| Jun 30, 2025 | 27.61 Mn |
| Mar 31, 2025 | 27.25 Mn |
| Dec 31, 2024 | 32.97 Mn |
| Sep 30, 2024 | 36.82 Mn |
| Jun 30, 2024 | 48.39 Mn |
| Mar 31, 2024 | 49.59 Mn |
| Dec 31, 2023 | 51.56 Mn |
| Sep 30, 2023 | 46.77 Mn |
| Jun 30, 2023 | 42.68 Mn |
| Mar 31, 2023 | 48.58 Mn |
| Dec 31, 2022 | 40.62 Mn |
| Sep 30, 2022 | 42.18 Mn |
| Jun 30, 2022 | 43.83 Mn |
| Mar 31, 2022 | 46.11 Mn |
| Dec 31, 2021 | 38.44 Mn |
| Sep 30, 2021 | 54.00 Mn |
| Jun 30, 2021 | 44.77 Mn |
| Mar 31, 2021 | 38.39 Mn |
| Dec 31, 2020 | 29.52 Mn |
| Sep 30, 2020 | 24.67 Mn |
| Jun 30, 2020 | 17.45 Mn |
| Mar 31, 2020 | 13.26 Mn |
| Dec 31, 2019 | 11.87 Mn |
| Sep 30, 2019 | 10.74 Mn |
| Jun 30, 2019 | 8.69 Mn |
| Mar 31, 2019 | 7.09 Mn |